Shrinivas Bishu

University of Michigan–Ann Arbor — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

32h-index3.5kcitations165works3.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Inflammatory Bowel Disease(55), Microscopic Colitis(35), Immunodeficiency and Autoimmune Disorders(16), Colorectal Cancer Screening and Detection(14), Gut microbiota and health(12)

Publications161 total

RUNX2 promotes epigenetic WNT signaling in inflamed intestinal epithelial cells
2025Open Access
Artificial Intelligence Analysis of Endoscopy Outperforms Conventional Endoscopic Scoring for Agreement with Symptoms and Quality of Life in a Phase 3 Ulcerative Colitis Trial
The American Journal of Gastroenterology·2025
IL-15 Promotes Inflammatory Th17 Cells in the Intestine
Inflammatory Bowel Diseases·2025Open Access
S1212 A Microscope to the Metabolome: A Systematic Review of Metabolomics in Irritable Bowel Syndrome
The American Journal of Gastroenterology·2025
S4859 A JAK of All Trades: The Novel Use of Upadacitinib in LRBA Deficiency-Related Autoimmune Enterocolitis
The American Journal of Gastroenterology·2025
S2028 Escalating the Dosage: A Meta-Analysis Comparing Standard and Intensified Infliximab for ASUC
The American Journal of Gastroenterology·2025
Artificial Intelligence for Quantifying Endoscopic Mucosal Ulceration in Crohn’s Disease
Clinical Gastroenterology and Hepatology·2025· 3 cited
The role of gastrointestinal PCR in inflammatory bowel disease flares: A double-edged sword or a diagnostic breakthrough?
Indian Journal of Gastroenterology·2025
A deeper quiet: Tofacitinib and the potential of endo-histologic remission
Indian Journal of Gastroenterology·2025Open Access
Evaluation of a virtual reality-directed brain-gut behavioural treatment inpatient program for patients with inflammatory bowel disease: protocol for a pilot feasibility trial
BMJ Open·2025Open Access
Tu1003: USING SIMULATION AND REAL-WORLD MULTICENTER DATA TO IDENTIFY OPTIMAL IBD PANEL SIZES: PLANNING FOR THE FUTURE OF IBD CARE
Gastroenterology·2025
Su1898: AUTOMATED BOWEL SYMPTOMS QUANTIFICATION AND CLASSIFICATION OF OVERALL IBD SYMPTOMATIC BURDEN FROM GASTROENTEROLOGY NOTES USING A LARGE LANGUAGE MODEL PIPELINE
Gastroenterology·2025
Tu1832: REAL-WORLD SAFETY OF UPADACITINIB IN ULCERATIVE COLITIS IN PATIENTS 50 YEARS OR OLDER: A MULTI-CENTER STUDY
Gastroenterology·2025
Mo1935: USING LONGITUDINAL C-REACTIVE PROTEIN MEASUREMENTS THROUGHOUT HOSPITALIZATION TO ASSESS COLECTOMY RISK IN PATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS
Gastroenterology·2025
483: ARTIFICIAL INTELLIGENCE SCORING IMPROVES ENDOSCOPIC ASSESSMENT AND AGREEMENT WITH SYMPTOMATIC REMISSION COMPARED TO CONVENTIONAL SCORING IN A PIVOTAL PHASE 3 ULCERATIVE COLITIS TRIAL
Gastroenterology·2025
Sa1915: SEQUENTIAL INFLIXIMAB AND JANUS KINASE INHIBIOR SALVAGE THERAPY FOR PATIENTS WITH ACUTE SEVERE ULCERATIVE COLITIS: A MULTICENTER EXPERIENCE
Gastroenterology·2025
Mo1987: FEATURES OF CHRONIC ABDOMINAL PAIN IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN REMISSION
Gastroenterology·2025
Mo1972: ARTIFICIAL INTELLIGENCE ENDOSCOPIC VIDEO SCORING IS STRONGLY ASSOCIATED WITH QUALITY OF LIFE ASSESSMENTS IN A PIVOTAL PHASE 3 ULCERATIVE COLITIS TRIAL
Gastroenterology·2025
A multicenter study of the real-world effectiveness and safety of risankizumab in Crohn’s disease
Journal of Crohn s and Colitis·2025· 6 cited
Immune phenotype-guided identification of disease-associated pathobionts in Crohn’s disease
2025Open Access
page 1 of 9Next →

Frequent Co-authors

Ryan W. Stidham(13), John Y. Kao(11), Peter Higgins(10), Helmut Grasberger(10), Mohamad El‐Zaatari(10), Nobuhiko Kamada(9), Akbar K. Waljee(8), Sarah L. Gaffen(6), Kathleen Schmidt(6), Carolyn Beebe Smith(6), Sho Kitamoto(5), Hiroko Nagao‐Kitamoto(5), Jeffrey Berinstein(5), Atsushi Hayashi(4), Kohei Sugihara(4), Kathryn A. Eaton(4), Michael Rice(4), Calen A. Steiner(4), Shirley Cohen‐Mekelburg(4), Min Zhang(4)